印度南部三级保健中心乳腺影像学报告和数据系统4病变结果分析。

IF 0.6 Q4 ONCOLOGY
Indian Journal of Surgical Oncology Pub Date : 2025-02-01 Epub Date: 2024-09-12 DOI:10.1007/s13193-024-02089-4
Lakshmi Revi, Chitrathara Kesava Pillai, Anupama Sreedhar, Sanam Puzhakkal
{"title":"印度南部三级保健中心乳腺影像学报告和数据系统4病变结果分析。","authors":"Lakshmi Revi, Chitrathara Kesava Pillai, Anupama Sreedhar, Sanam Puzhakkal","doi":"10.1007/s13193-024-02089-4","DOIUrl":null,"url":null,"abstract":"<p><p>The Breast Imaging Reporting and Data System (BIRADS) is a reporting system used to describe the results of mammogram, breast ultrasound, or breast MRI in a standard way. BIRADS ranks the test findings according to one of the seven categories, ranging from normal or benign to highly suspicious of cancer or malignant. This has specific accuracy for breast cancer. Out of the seven categories, BIRADS 4 is linked with a greater possibility for carcinoma breast. The research objective was to establish the rate of malignancy and clinical net result of BIRADS 4 lesions. The retrospective study, conducted in in Lakeshore Hospital and Research Centre (LHRC), Kochi, for a duration of 3 years, from December 2019 to December 2022, includes patients diagnosed as BIRADS 4 by mammographic or ultrasonographic or MRI findings. Previous medical records and electronic database were used to collect data. The study includes patients with BIRADS 4 lesions who went through surgery. Predictors such as patient demographics, comorbidities, and imaging features were considered. The rate of malignancy and positive predictive factor of BIRADS 4 lesions associated with carcinoma breast was calculated. A total of 394 lesions were classified as BIRADS 4 according to mammogram, ultrasound, or MRI for a time period of 3 years, from December 2019 to December 2022 at LHRC. Nevertheless, only 383 BIRADS 4 lesions for whom surgery was done were included in the survey. Out of the 383 lesions, the final histopathological report of the biopsied samples revealed 339 lesions to be malignant. Multivariate logistic regression analysis showed that menopausal status, mass lesions and spiculations in mammogram, and ductal abnormality in ultrasonography were greatly linked with carcinoma breast. Invasive breast carcinoma was the most common malignant lesion while fibro-cystic disease remained the predominant benign pathology. This study showed that majority of the BIRADS 4 lesions in LHRC were malignant. Both mammogram and ultrasonography were able to pick up early-stage breast cancer. Tissue diagnosis had higher sensitivity and is useful to avoid surgeries for non-significant lesions which can be followed up. Routine health check-up should be done according to the recent guidelines to detect early-stage breast cancer.</p>","PeriodicalId":46707,"journal":{"name":"Indian Journal of Surgical Oncology","volume":"16 1","pages":"312-319"},"PeriodicalIF":0.6000,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11920482/pdf/","citationCount":"0","resultStr":"{\"title\":\"An Analysis of the Results of Breast Imaging Reporting and Data System 4 Lesions in Tertiary Care Center in South India.\",\"authors\":\"Lakshmi Revi, Chitrathara Kesava Pillai, Anupama Sreedhar, Sanam Puzhakkal\",\"doi\":\"10.1007/s13193-024-02089-4\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>The Breast Imaging Reporting and Data System (BIRADS) is a reporting system used to describe the results of mammogram, breast ultrasound, or breast MRI in a standard way. BIRADS ranks the test findings according to one of the seven categories, ranging from normal or benign to highly suspicious of cancer or malignant. This has specific accuracy for breast cancer. Out of the seven categories, BIRADS 4 is linked with a greater possibility for carcinoma breast. The research objective was to establish the rate of malignancy and clinical net result of BIRADS 4 lesions. The retrospective study, conducted in in Lakeshore Hospital and Research Centre (LHRC), Kochi, for a duration of 3 years, from December 2019 to December 2022, includes patients diagnosed as BIRADS 4 by mammographic or ultrasonographic or MRI findings. Previous medical records and electronic database were used to collect data. The study includes patients with BIRADS 4 lesions who went through surgery. Predictors such as patient demographics, comorbidities, and imaging features were considered. The rate of malignancy and positive predictive factor of BIRADS 4 lesions associated with carcinoma breast was calculated. A total of 394 lesions were classified as BIRADS 4 according to mammogram, ultrasound, or MRI for a time period of 3 years, from December 2019 to December 2022 at LHRC. Nevertheless, only 383 BIRADS 4 lesions for whom surgery was done were included in the survey. Out of the 383 lesions, the final histopathological report of the biopsied samples revealed 339 lesions to be malignant. Multivariate logistic regression analysis showed that menopausal status, mass lesions and spiculations in mammogram, and ductal abnormality in ultrasonography were greatly linked with carcinoma breast. Invasive breast carcinoma was the most common malignant lesion while fibro-cystic disease remained the predominant benign pathology. This study showed that majority of the BIRADS 4 lesions in LHRC were malignant. Both mammogram and ultrasonography were able to pick up early-stage breast cancer. Tissue diagnosis had higher sensitivity and is useful to avoid surgeries for non-significant lesions which can be followed up. Routine health check-up should be done according to the recent guidelines to detect early-stage breast cancer.</p>\",\"PeriodicalId\":46707,\"journal\":{\"name\":\"Indian Journal of Surgical Oncology\",\"volume\":\"16 1\",\"pages\":\"312-319\"},\"PeriodicalIF\":0.6000,\"publicationDate\":\"2025-02-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11920482/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Indian Journal of Surgical Oncology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1007/s13193-024-02089-4\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/9/12 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q4\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Indian Journal of Surgical Oncology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/s13193-024-02089-4","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/9/12 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

乳房成像报告和数据系统(BIRADS)是一个报告系统,用于以标准的方式描述乳房x光检查、乳房超声检查或乳房MRI检查的结果。BIRADS根据七个类别中的一个对检测结果进行排名,从正常或良性到高度怀疑癌症或恶性。这对乳腺癌有特殊的准确性。在这七种类型中,BIRADS 4与患乳腺癌的可能性更大有关。研究目的是建立BIRADS 4型病变的恶性率和临床净结果。该回顾性研究于2019年12月至2022年12月在高知湖岸医院和研究中心(LHRC)进行,为期3年,包括通过乳房x光检查或超声检查或MRI结果诊断为BIRADS 4的患者。使用既往病历和电子数据库收集数据。该研究包括接受手术的BIRADS 4病变患者。预测因素如患者人口统计学、合并症和影像学特征被考虑在内。计算乳腺癌相关BIRADS 4病变的恶性率及阳性预测因子。LHRC从2019年12月至2022年12月,在3年的时间里,根据乳房x光片、超声或MRI,共有394个病变被分类为BIRADS 4。然而,只有383例手术治疗的BIRADS 4病变被纳入调查。在383个病变中,活检样本的最终组织病理学报告显示339个病变是恶性的。多因素logistic回归分析显示,绝经状态、乳房x光检查肿块病变、肿块、超声检查导管异常与乳腺癌的发生密切相关。浸润性乳腺癌是最常见的恶性病变,而纤维囊性疾病仍然是主要的良性病理。本研究显示,LHRC中BIRADS - 4病变多数为恶性。乳房x光检查和超声检查都能发现早期乳腺癌。组织诊断具有较高的敏感性,有助于避免非显著病变的手术,可以随访。应根据最新的早期乳腺癌检测指南进行常规健康检查。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
An Analysis of the Results of Breast Imaging Reporting and Data System 4 Lesions in Tertiary Care Center in South India.

The Breast Imaging Reporting and Data System (BIRADS) is a reporting system used to describe the results of mammogram, breast ultrasound, or breast MRI in a standard way. BIRADS ranks the test findings according to one of the seven categories, ranging from normal or benign to highly suspicious of cancer or malignant. This has specific accuracy for breast cancer. Out of the seven categories, BIRADS 4 is linked with a greater possibility for carcinoma breast. The research objective was to establish the rate of malignancy and clinical net result of BIRADS 4 lesions. The retrospective study, conducted in in Lakeshore Hospital and Research Centre (LHRC), Kochi, for a duration of 3 years, from December 2019 to December 2022, includes patients diagnosed as BIRADS 4 by mammographic or ultrasonographic or MRI findings. Previous medical records and electronic database were used to collect data. The study includes patients with BIRADS 4 lesions who went through surgery. Predictors such as patient demographics, comorbidities, and imaging features were considered. The rate of malignancy and positive predictive factor of BIRADS 4 lesions associated with carcinoma breast was calculated. A total of 394 lesions were classified as BIRADS 4 according to mammogram, ultrasound, or MRI for a time period of 3 years, from December 2019 to December 2022 at LHRC. Nevertheless, only 383 BIRADS 4 lesions for whom surgery was done were included in the survey. Out of the 383 lesions, the final histopathological report of the biopsied samples revealed 339 lesions to be malignant. Multivariate logistic regression analysis showed that menopausal status, mass lesions and spiculations in mammogram, and ductal abnormality in ultrasonography were greatly linked with carcinoma breast. Invasive breast carcinoma was the most common malignant lesion while fibro-cystic disease remained the predominant benign pathology. This study showed that majority of the BIRADS 4 lesions in LHRC were malignant. Both mammogram and ultrasonography were able to pick up early-stage breast cancer. Tissue diagnosis had higher sensitivity and is useful to avoid surgeries for non-significant lesions which can be followed up. Routine health check-up should be done according to the recent guidelines to detect early-stage breast cancer.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
1.10
自引率
0.00%
发文量
190
期刊介绍: The Indian Journal of Surgical Oncology aims to encourage and promote clinical and research activities pertaining to Surgical Oncology. It also aims to bring in the concept of multidisciplinary team approach in management of various cancers. The Journal would publish original article, point of technique, review article, case report, letter to editor, profiles of eminent teachers, surgeons and instititions - a short (up to 500 words) of the Cancer Institutions, departments, and oncologist, who founded new departments.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信